cidrap.umn5d
Shorter, all-oral drug-resistant TB regimens perform well in real-world setting, study finds
In a study in Belarus and Uzbekistan, 96% of patients with drug-resistant TB who received the regimens had successful treatment outcomes.
Maharashtra to start six-month drug-resistant TB treatment regime
According to the officials, the new regimen, called BPaL/BPaLM, includes medications bedaquiline, pretomanid, linezolid, and moxifloxacin and will be given to multi-drug-resistant TB patients ...
JJ leads in shorter treatment rollout for MDR-TB in Maha
Mumbai: At the state-run JJ Hospital in Byculla, 10 patients, including two teenagers, received early access to the ...